Ontology highlight
ABSTRACT:
SUBMITTER: Namikawa K
PROVIDER: S-EPMC5896686 | biostudies-other | 2017 Jul
REPOSITORIES: biostudies-other
Namikawa Kenjiro K Tsutsumida Arata A Mizutani Tomonori T Shibata Taro T Takenouchi Tatsuya T Yoshikawa Shusuke S Kiyohara Yoshio Y Uchi Hiroshi H Furue Masutaka M Ogata Dai D Tsuchida Tetsuya T Yamazaki Naoya N
Japanese journal of clinical oncology 20170701 7
The Dermatologic Oncology Group of Japan Clinical Oncology Group has started a randomized phase III trial to confirm the superiority of adjuvant therapy with locoregional interferon beta in overall survival over surgery alone for patients with pathological stage II/III cutaneous melanoma (JCOG1309). Patients in the interferon beta arm receive intra- or subcutaneous injections of interferon beta directly into the surgical site at a flat dose of 3 million units once per day. Treatment is repeated ...[more]